Harry Agis, MD, is a vascular surgeon and a partner in the New Jersey Vein Institute, Morristown, NJ. He speaks with Internal Medicine World Report Editor-in-Chief, Simon Douglas Murray, MD about the utility of the ankle-brachial index (ABI) in screening for peripheral artery disease and atherosclerosis and then will touch briefly on a few other subjects that might be relevant to internists with regards to vascular surgery.
The Ebola epidemic in Central Africa has riveted the American public. Press accounts of the homegrown case of a Liberian man who developed symptoms after arriving in Texas has driven anxiety higher. There is growing fear among many that the virus will spread rapidly in the US causing widespread death. This week a patient advised me to stock up on food and water and get a gun to prepare for the impending epidemic.
A study published in the Journal of the American Medical Association found hospitals' administration of pharmacologic venous thromboembolism (VTE) prophylaxis was not associated with lower rates of VTE.
In a review published in the New England Journal of Medicine, Brett noted that the results from the first study suggested that in Taiwan, one out of every 200 patients who are "long-term users of oral alendronate," develop the condition.
In an article in Annals of Surgery, Debbi Li, MD and colleagues at the University of Toronto, Toronto, Ontario, Canada report on a retrospective study of 14,124 diverticulitis patients cared for without surgery. The research goal was to quantify the risks of readmission and emergency surgery when patients did not get a prophylactic colectomy.
Patients of Indian ancestry living in the United States are at greater risk for all types of inflammatory bowel disease (IBD) than other American populations, according to a new study by Reenu Malhotra, MD, and colleagues published online in Clinical Gastroenterology and Hepatology on July 29, 2014.
A recent study published in the Canadian Medical Association Journal looked at the steady progression of treatments for patients with degenerative muscular tears as well as the different efficiency levels between those patients who had surgery and those who took another treatment option.
Physicians have few effective weapons to treat a migraine, an ailment that accounts for more than half of disability with a neurological cause. Chronic migraine is said to affect 2% of the world's population.
For individuals without diabetes, hemoglobin A1c (HbA1c) levels not only predicted the prevalence of coronary artery disease (CAD), but also anticipated its severity, according to research published in Mayo Clinic Proceedings.
Clostridium difficile (C. diff) infection is now the leading cause of infectious nosocomial diarrhea in the industrialized world. But by following Infectious Disease Society of America (IDSA) treatment guidelines, clinicians can significantly reduce recurrence and mortality, a Texas Tech University Health Sciences Center School of Pharmacy team reports.
Scientists from Sanofi Pasteur's Swiftwater, PA facility have published results of a study indicating that a high-dose, trivalent, inactivated influenza vaccine (IIV3-HD or high dose Fluzone®) improves antibody responses to influenza among adults 65 years of age or older.
Prescription medications for mental health diagnoses (e.g. antidepressants, antipsychotics, and mood stabilizers) consume approximately 25% of commercial health insurers' pharmacy budgets and almost 35% of public payers' pharmacy spending. In 2011, an estimated 26.8 million US adults-more than 11%-took prescription medications for mental illness.
As people spend more time sitting and working in front of computer screens, studies have shown the risk of developing carpal tunnel syndrome (CTS) has grown. A team of researchers recently worked to take a deeper look at specific factors and their roles in the development in the condition.
Cannabis users who acknowledge their problem and report withdrawal symptoms are likely to increase abstinence over a 12-month period, according to research published in the Journal of Addiction Medicine.